Diego Brandao Tests Positive For Marijuana Following UFC 195

Diego Brandao failed a drug test following his loss to Brian Ortega at UFC 195. The UFC announced the news today, noting that Brandao had the presence of Carboxy-Tetrahydrocannabinol — marijuana metabolites — in his system.

The statement reads, “The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) informed Diego Brandao of a potential Anti-Doping Policy violation involving Carboxy-Tetrahydrocannabinol (“Carboxy-THC”) which is a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, stemming from an in-competition sample collected following his fight on January 2, 2016 in Las Vegas.

“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Brandao, as it relates to the UFC Anti-Doping Policy and future UFC participation,” the statement continued. “Because the Nevada State Athletic Commission was the regulatory body overseeing the fight in Las Vegas and has state licensing and jurisdiction over Brandao, USADA will work to ensure that the Commission has the necessary information to determine its proper judgment of Brandao’s potential anti-doping violation. Additional information will be provided at the appropriate time as the process moves forward.”

The loss ended a two-fight winning streak for Brandao.